It was discovered that activating NF-κB in HCC cells resulted in a long-term elevation in HIF-2α levels, which consequently lowered the susceptibility of hepatoma cells to Sor [36, 37]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.